Pathophysiological mechanisms explaining poor clinical outcome of older cancer patients with low skeletal muscle mass

Low skeletal muscle mass is highly prevalent in older cancer patients and affects 5% to 89% depending on the type and stage of cancer. Low skeletal muscle mass is associated with poor clinical outcomes such as post‐operative complications, chemotherapy toxicity and mortality in older cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Looijaard, Stéphanie M. L. M., te Lintel Hekkert, Miriam L., Wüst, Rob C. I., Otten, René H. J., Meskers, Carel G. M., Maier, Andrea B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757176/
https://www.ncbi.nlm.nih.gov/pubmed/32478975
http://dx.doi.org/10.1111/apha.13516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757176/
https://www.ncbi.nlm.nih.gov/pubmed/32478975
http://dx.doi.org/10.1111/apha.13516

Ejemplares similares